普米克令舒雾化吸入治疗小儿喘息性肺炎的疗效分析

Effect of Pulmicort in Treating Infant Asthmatic Pneumonia by Aerosol Inhalation Therapy:Clinical Obervation

目的分析普米克令舒雾化吸入治疗小儿喘息性肺炎的临床疗效。方法选取我院收治的127例小儿喘息性肺炎患儿,随机分为观察组(64例)和对照组(63例)。所有患儿均给予吸氧、抗感染治疗、抗病毒治疗、激素治疗及止咳、化痰、退热等对症治疗。观察组患儿在此基础上给予普米克令舒雾化吸入治疗。记录比较两组患儿咳嗽消失时间、气喘缓解时间、肺部哮鸣音及湿啰音消失时间、肺部X线影像恢复时间、住院时间及治疗7d后临床总有效率。结果观察组患儿应用普米克令舒雾化吸入治疗后,咳嗽消失、气喘缓解、湿啰音消失、肺部X线影响恢复及住院时间均显著小于对照组患儿(P<0.01);观察组患儿接受治疗7d后总有效率92.2%显著高于对照组77.8%(P<0.05)。结论普米克令舒雾化吸入治疗小儿喘息性肺炎可显著缓解临床症状、缩短病程,具有良好疗效,值得临床推广应用。

Objective To research the effect of pulmicort in treating infant asthmatic pneumonia by aerosol inhalation therapy.Method Divide 127 asthmatic pneumonia infants into 2 groups.All the infants were given the treatment of oxygenuptake,Antiinflammation,virussafe hormonotherapy and symptomatic treatment.The 64 infants in the observation group were given the inhalation therapy of pulmicort.Recorded and compared the days of wheezing disappearance,the days of coughing significantly alleviating,the days of pulmonary rales disappearance,the days of hospital stays and the clinical effect after 7days’ treatment.Results The days of the clinical symptoms disappearance and hospital stays of the observation group were all significantly lower than those of the control group（P0.01） while the effective rate after 7days’treatment was significantly higher（P0.05）.Conclusion The effect of the inhalation therapy of pulmicort is remarkable in treating infant asthmatic pneumonia.